Martina Paola Zanaboni

Martina Paola Zanaboni

Auto-generated profile, based on publicly available information

Martina Paola Zanaboni

Child Neurology and Psychiatry Unit IRCCS Mondino Foundation, Full Member of European Reference Network EpiCARE Pavia Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Epileptic Disorders
Verified
Journal Article
Closed access
MZMartina Paola Zanaboni
Martina Paola Zanaboni
LPLudovica Pasca
Ludovica Pasca
SBStefania Maria Bova
Stefania Maria Bova
Matteo ChiappediMatteo Chiappedi
Matteo Chiappedi
MFMelissa Filippini
Melissa Filippini
TGThe EpilEpsyIt study group
The EpilEpsyIt study group

29 May 2025 in Epilepsia Open
Verified
Journal Article
Open access
KFKelly Faltersack
Kelly Faltersack
TMTanya McDonanld
Tanya McDonanld
Valentina De GiorgisValentina De Giorgis
Valentina De Giorgis
BBBobbie Barron
Bobbie Barron
MCMackenzie Cervenka
Mackenzie Cervenka
EFElizabeth Felton
Elizabeth Felton
Objective: Ketogenic diet therapies (KDTs) are increasingly used as a treatment for people with epilepsy of childbearing potential (PWECP) and glucose transporter type 1 deficiency syndrome (Glut1DS). The aim of this study was to collect information on clinical experience with KDT during pregnancy and lactation in these populations. Methods: Between December 2023 and June 2024, an online survey was widely circulated to healthcare professionals (HCPs) working with PWECP and people with Glut1DS of childbearing potential on KDT. The survey explored KDT use during pregnancy and lactation. Only HCPs working with patients who expressed interest in KDT and who were planning to become pregnant or were already pregnant were invited to complete the survey. Results: Thirty‐five HCPs had counseled patients about whether to follow KDT during pregnancy. Sixty percent of HCPs did not recommend KDT during pregnancy. Key concerns included a lack of expertise with KDT use during pregnancy, insufficient data on the safety of KDT use during pregnancy, and uncertainty about the impact on fetal development. Among the HCPs (40%) who recommended KDT during pregnancy, there was no consensus regarding the version of KDT or optimal macronutrient composition. Even fewer HCPs ( n = 5) had provided counseling on diet adaptation during lactation. Low Glycemic Index Treatment and the modified Atkins diet were most recommended. Blood ketone monitoring was unanimously recommended during lactation. Significance: Based on the survey results, HCPs have variable opinions about the safety, management, ideal diet, and levels of ketosis for people with epilepsy (PWE) and Glut1DS on KDT during pregnancy and lactation. There was consensus about monitoring ketosis levels and ensuring micronutrient supplementation. Patient enrollment in pregnancy registries that capture KDT use is crucial to support future research and expand knowledge about the safety of KDT so HCPs and PWE or Glut1DS can make informed decisions about their treatment. Plain Language Summary: Most healthcare providers (HCPs) did not advise ketogenic diet therapy (KDT) for epilepsy during pregnancy, though some noted exceptions for glucose transporter type 1 deficiency syndrome. Their main concerns were not having enough information about safety for the parent and fetus and their own lack of experience using KDT during pregnancy. The 40% of HCPs who supported the use of KDT during pregnancy stressed the need for personalized care and close monitoring to reduce risks. Few HCPs have used KDT during lactation. Experts advised using more flexible versions of KDT during lactation. More research is needed.

1 April 2021 in Minerva Pediatrics
Verified
Journal Article
Closed access
CVCostanza Varesio
Costanza Varesio
MZMartina P. Zanaboni
Martina P. Zanaboni
LPLudovica Pasca
Ludovica Pasca
Livio ProvenziLivio Provenzi
Livio Provenzi
Cinzia FerrarisCinzia Ferraris
Cinzia Ferraris
Valentina De GiorgisValentina De Giorgis
Valentina De Giorgis
Article: Novel insight into GLUT1 Deficiency Syndrome: screening for emotional and behavioral problems in youths following ketogenic diet - Minerva Pediatrics 2021 Apr 02 - Minerva Medica - Journals

11 July 2026 in Epileptic Disorders
Verified
Journal Article
Open access
PDF file
Carlo Alberto QuarantaCarlo Alberto Quaranta
Carlo Alberto Quaranta
MZMartina Paola Zanaboni
Martina Paola Zanaboni
ERElena Ripamonti
Elena Ripamonti
GGGaia Garghetti
Gaia Garghetti
MCMassimiliano Celario
Massimiliano Celario
LPLudovica Pasca
Ludovica Pasca
Background: Idiopathic Generalized Epilepsies (IGEs) are electroclinical syndromes characterized by distinct seizure types, EEG patterns, and presumed polygenic inheritance. While seizure prognosis is often favorable, sleep disturbances, behavioral and emotional difficulties, and executive function impairment are common, especially during adolescence. Objective: To investigate the relationship between subjective sleep quality, emotional–behavioral functioning, and executive functions in adolescents with IGE. Methods: In this single‐center observational study, 28 adolescents (mean age 15.0 ± 2.4 years) with IGE were evaluated with the following standardized measures: PSQI (sleep), BRIEF‐2 (executive functions), CBCL and YSR (emotional–behavioral profile), SAFA‐A/‐D/‐S (internalizing and somatic symptoms). Dream‐related experiences were also collected. Pearson correlations tested behavioral and emotional associations with sleep quality. Results: Poor sleep quality (PSQI ≥5) occurred in 28.6% of patients, although only 14.8% reported sleep problems in their clinical history. Poor sleepers showed significantly higher anxiety, depression, somatic complaints, and stress‐related symptoms ( p < .05). Executive function impairment, particularly in emotional control and cognitive flexibility, was more frequent in this group. Significance: Sleep quality is an under‐recognized but clinically relevant dimension in patients with IGE, closely linked to emotional vulnerability and executive function difficulties. Routine sleep screening and targeted sleep‐focused management should be integrated into pediatric IGE care to support psychological well‐being.

16 October 2026 in Epilepsy & Behavior Reports
Verified
Journal Article
Open access
MZMartina Paola Zanaboni
Martina Paola Zanaboni
CCCinzia Correale
Cinzia Correale
TMTiziana Metitieri
Tiziana Metitieri
VMValentina Manfredi
Valentina Manfredi
FOFrancesca Offredi
Francesca Offredi
SCSimona Cappelletti
Simona Cappelletti

14 February 2026 in Epilepsy & Behavior
Verified
Journal Article
Open access
MZMartina Paola Zanaboni
Martina Paola Zanaboni
ARAlessandra Raspanti
Alessandra Raspanti
Carlo Alberto QuarantaCarlo Alberto Quaranta
Carlo Alberto Quaranta
MBMaria Stefania Bova
Maria Stefania Bova
MCMassimiliano Celario
Massimiliano Celario
Valentina De GiorgisValentina De Giorgis
Valentina De Giorgis
This exploratory cross-sectional multicenter study evaluated the presence of depression and anxiety traits in adolescents with idiopathic generalized epilepsy (IGE) and explored their association with epilepsy-related clinical variables. Sixty-eight patients aged 11-18 years with a confirmed IGE diagnosis participated. Emotional symptoms were assessed using the parent-reported Child Behavior Checklist (CBCL) and the self-reported Psychiatric Scales for Self-Administration for Youths and Adolescents (SAFA). While no clinically significant deficits emerged on the overall CBCL or SAFA scores, 33% of patients showed clinically relevant anxiety traits, 31% showed depressive symptoms, and 19% reported clinically significant somatic complaints. Correlation analyses showed that somatic symptoms were significantly associated with epilepsy-related variables. Higher somatic symptom scores were related to a shorter time since the last seizure and a later age at epilepsy onset, while an inverse association was observed with epilepsy duration. These findings suggest that affective symptoms in adolescents with IGE are linked to specific clinical characteristics of epilepsy. The results highlight the importance of comprehensive emotional assessment and targeted psychological support for this population.